Medbox Completes Auditor Review of Q1 2013 Financials
Company to re-file registration document with SEC on July 8th, 2013
HOLLYWOOD, Calif., July 1, 2013 /PRNewswire/ -- Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), a leader in providing industry specific consulting services and patented systems to the medical and retail industries, announced completion of its quarterly financial review by its Public Company Accounting Oversight Board (PCAOB) registered auditing firm.
The company now has all that is needed to re-file a registration statement with the Securities and Exchange Commission and it plans on doing so by next Monday. The filing will also include answers to comments posed by the SEC upon a prior filing. Based on the company's belief that it will adequately address any prior comments by the SEC within the re-filed registration statement, Medbox management anticipates the filing will be deemed effective within the 3rd quarter of this year.
"I am extremely pleased with our progress to date," stated Vincent Mehdizadeh, Chief Operations Officer of Medbox, Inc. "We are light years ahead in all phases on being a transparent company, and the standard for all companies operating in the medical marijuana ancillary service industry to emulate. We take pride in that role and relish the opportunity to bring value to shareholders and provide excellent service to our clients. Although the medical marijuana industry is not our only target market and we have developed products and services geared at traditional pharmaceuticals, regulating how medical marijuana is dispensed is still our focus and we feel that niche market is in its infancy."
About Medbox, Inc:
Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Arizona, Connecticut, Massachusetts, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.
Medbox provides their patented systems, software and consulting services to pharmacies, dispensaries, urgent care centers, drug rehab clinics, hospitals, prison systems, hospice facilities, and medical groups worldwide.
Medbox, Inc. is a publicly traded company, and is quoted on the OTC Markets, ticker symbol MDBX.
For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.
Forward-Looking Statements: The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry, political conditions and economic conditions in the states considering such legislation. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.
SOURCE Medbox, Inc.
More by this Source
Medbox Issues Shareholder Update
Mar 10, 2014, 09:00 ET
Medbox Expands Licensing Agreement with Bio-Tech Medical Software
Mar 06, 2014, 09:00 ET
Medbox To Lobby For Compassionate Care Act And Governor Cuomo's Executive Order
Mar 05, 2014, 16:08 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.